Effect of inhibiting the signal of mammalian target of rapamycin on memory T cells

Transplantation Proceedings

Volumn 46, Issue 5, 2014, Pages 1642-1648

  Chen, S ^a   Liu, D ^a   Wu, J ^b   Xu, B ^a   Lu, K ^a   Zhu, W ^a   Chen, M ^a  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAX; PROTEIN BCL 2; MTOR PROTEIN, MOUSE; PRIMER DNA; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; IN VITRO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; FLOW CYTOMETRY; KNOCKOUT MOUSE; METABOLISM; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84902507904     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.10.063     Document Type: Article

References (23)

1. J.L. Miller Sirolimus approved with renal transplant indication Am J Health Syst Pharm 56 1999 2177
2. W. Cao, S. Manicassamy, and H. Tang et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway Nat Immunol 9 2008 1157
3. S. Sauer, L. Bruno, and A. Hertweck et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR Proc Natl Acad Sci U S A 105 2008 7797
4. S. Haxhinasto, D. Mathis, and C. Benoist The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells J Exp Med 205 2008 565
5. L.V. Sinclair, D. Finlay, and C. Feijoo et al. Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking Nat Immunol 9 2008 513
6. S.C. Woods, R.J. Seeley, and D. Cota Regulation of food intake through hypothalamic signaling networks involving mTOR Annu Rev Nutr 28 2008 295
7. C. Vezina, A. Kudelski, and S.N. Sehgal Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle J Antibiot (Tokyo) 28 1975 721
8. A. Mondino, and D.L. Mueller mTOR at the crossroads of T cell proliferation and tolerance Semin Immunol 19 2007 162
9. K. Araki, A.P. Turner, and V.O. Shaffer et al. mTOR regulates memory CD8 T-cell differentiation Nature 460 2009 108
10. Y. Zheng, S.L. Collins, and M.A. Lutz et al. A role for mammalian target of rapamycin in regulating T cell activation versus anergy J Immunol 178 2007 2163
11. R.R. Rao, Q. Li, and K. Odunsi et al. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin Immunity 32 2010 67
12. R.J. Salmond, and R. Zamoyska How does the mammalian target of rapamycin (mTOR) influence CD8 T cell differentiation? Cell Cycle 9 2010 2952
13. J.M. Slavik, D.G. Lim, and S.J. Burakoff et al. Uncoupling p70(s6) kinase activation and proliferation: rapamycin-resistant proliferation of human CD8(+) T lymphocytes J Immunol 166 2001 3201
14. X.C. Li, P. Roy-Chaudhury, and W.W. Hancock et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection J Immunol 161 1998 890
15. A.W. Goldrath, L.Y. Bogatzki, and M.J. Bevan Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation J Exp Med 192 2000 557
16. A.W. Goldrath, C.J. Luckey, and R. Park et al. The molecular program induced in T cells undergoing homeostatic proliferation Proc Natl Acad Sci U S A 101 2004 16885
17. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471
18. D.A. Guertin, and D.M. Sabatini Defining the role of mTOR in cancer Cancer Cell 12 2007 9
19. G.M. Delgoffe, T.P. Kole, and Y. Zheng et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment Immunity 30 2009 832
20. G.M. Delgoffe, K.N. Pollizzi, and A.T. Waickman et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2 Nat Immunol 12 2011 295
21. S. Colombetti, F. Benigni, and V. Basso et al. Clonal anergy is maintained independently of T cell proliferation J Immunol 169 2002 6178
22. K. Araki, B. Youngblood, and R. Ahmed The role of mTOR in memory CD8 T-cell differentiation Immunol Rev 235 2010 234
23. H. Liang, F. Yu, and Z. Tong et al. Effect of ischemia post-conditioning on skeletal muscle oxidative injury, mTOR, Bax, Bcl-2 proteins expression, and HIF-1alpha/beta-actin mRNA, IL-6/beta-actin mRNA and caveolin-3/beta-actin mRNA expression in ischemia-reperfusion rabbits Mol Biol Rep 40 2013 507